BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar V, Behera R, Lohite K, Karnik S, Kundu GC. p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression. Cancer Res. 2010;70:10381-10391. [PMID: 20980434 DOI: 10.1158/0008-5472.can-10-1470] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Marshall JC, Collins JW, Nakayama J, Horak CE, Liewehr DJ, Steinberg SM, Albaugh M, Vidal-Vanaclocha F, Palmieri D, Barbier M, Murone M, Steeg PS. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer. J Natl Cancer Inst 2012;104:1306-19. [PMID: 22911670 DOI: 10.1093/jnci/djs319] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 8.5] [Reference Citation Analysis]
2 Huang R, Rofstad EK. Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget. 2017;8:35351-35367. [PMID: 27343550 DOI: 10.18632/oncotarget.10169] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 14.3] [Reference Citation Analysis]
3 Kumar D, Haldar S, Gorain M, Kumar S, Mulani FA, Yadav AS, Miele L, Thulasiram HV, Kundu GC. Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway. BMC Cancer 2018;18:52. [PMID: 29310608 DOI: 10.1186/s12885-017-3876-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
4 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
6 Couture F, D'Anjou F, Day R. On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications. Biomol Concepts 2011;2:421-38. [PMID: 22308173 DOI: 10.1515/bmc.2011.034] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
7 Wang J, Ou J, Guo Y, Dai T, Li X, Liu J, Xia M, Liu L, He M. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer. Br J Cancer 2014;111:112-24. [PMID: 24874481 DOI: 10.1038/bjc.2014.278] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
8 Adu-Agyeiwaah Y, Grant MB, Obukhov AG. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes. Cells 2020;9:E2528. [PMID: 33238570 DOI: 10.3390/cells9112528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Giopanou I, Lilis I, Papaleonidopoulos V, Agalioti T, Kanellakis NI, Spiropoulou N, Spella M, Stathopoulos GT. Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis. Oncoimmunology 2017;6:e1256528. [PMID: 28197374 DOI: 10.1080/2162402X.2016.1256528] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
10 Stramucci L, Pranteda A, Bossi G. Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer. Cancers (Basel) 2018;10:E131. [PMID: 29751559 DOI: 10.3390/cancers10050131] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 10.8] [Reference Citation Analysis]
11 Nookala AR, Shah A, Noel RJ, Kumar A. HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways. PLoS One 2013;8:e78855. [PMID: 24244375 DOI: 10.1371/journal.pone.0078855] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
12 Fu J, Zhang J, Gong Y, Testa CL, Klein-Szanto AJ. Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells. Mol Carcinog 2015;54:698-706. [PMID: 24436242 DOI: 10.1002/mc.22131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
13 Shevde LA, Samant RS. Role of osteopontin in the pathophysiology of cancer. Matrix Biol 2014;37:131-41. [PMID: 24657887 DOI: 10.1016/j.matbio.2014.03.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 140] [Article Influence: 17.5] [Reference Citation Analysis]
14 Siegfried G, Descarpentrie J, Evrard S, Khatib AM. Proprotein convertases: Key players in inflammation-related malignancies and metastasis. Cancer Lett 2020;473:50-61. [PMID: 31899298 DOI: 10.1016/j.canlet.2019.12.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
15 Chen Y, Guo M, Qu D, Liu Y, Guo J, Chen Y. Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation. Drug Deliv 2020;27:1608-24. [PMID: 33179521 DOI: 10.1080/10717544.2020.1827086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Butti R, Nimma R, Kundu G, Bulbule A, Kumar TVS, Gunasekaran VP, Tomar D, Kumar D, Mane A, Gill SS, Patil T, Weber GF, Kundu GC. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression. Oncogene 2021;40:2002-17. [PMID: 33603163 DOI: 10.1038/s41388-021-01663-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ju M, Qi A, Bi J, Zhao L, Jiang L, Zhang Q, Wei Q, Guan Q, Li X, Wang L, Wei M, Zhao L. A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer. J Cell Mol Med 2020;24:6283-97. [PMID: 32306508 DOI: 10.1111/jcmm.15270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Feng YF, Lei YY, Lu JB, Xi SY, Zhang Y, Huang QT, Wu QL, Wang F. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Cell Death Dis 2018;9:1085. [PMID: 30348939 DOI: 10.1038/s41419-018-0979-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Madapusi Balaji T, Varadarajan S, Rao USV, Raj AT, Patil S, Arakeri G, Brennan PA. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression. Med Hypotheses 2020;144:109936. [PMID: 32505073 DOI: 10.1016/j.mehy.2020.109936] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
20 Yushi Q, Li Z, Von Roemeling CA, Doeppler H, Marlow LA, Kim BY, Radisky DC, Storz P, Copland JA, Tun HW. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. Oncotarget 2016;7:32156-71. [PMID: 27050077 DOI: 10.18632/oncotarget.8537] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
21 Wang W, Wei Q, Hao Q, Zhang Y, Li Y, Bi Y, Jin Z, Liu H, Liu X, Yang Z, Xiao S. Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts. Front Microbiol 2021;12:607451. [PMID: 33603723 DOI: 10.3389/fmicb.2021.607451] [Reference Citation Analysis]
22 Katopodis P, Kerslake R, Zikopoulos A, Beri N, Anikin V. p38β - MAPK11 and its role in female cancers. J Ovarian Res 2021;14:84. [PMID: 34174910 DOI: 10.1186/s13048-021-00834-9] [Reference Citation Analysis]
23 Nookala AR, Kumar A. Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes. J Neuroinflammation 2014;11:214. [PMID: 25539898 DOI: 10.1186/s12974-014-0214-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
24 Cheng Y, Qiao Z, Dang C, Zhou B, Li S, Zhang W, Jiang J, Song Y, Zhang J, Diao D. p38 predicts depression and poor outcome in esophageal cancer. Oncol Lett 2017;14:7241-9. [PMID: 29344159 DOI: 10.3892/ol.2017.7129] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Mishra R, Thorat D, Soundararajan G, Pradhan SJ, Chakraborty G, Lohite K, Karnik S, Kundu GC. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. Oncogene 2015;34:1584-95. [PMID: 24727891 DOI: 10.1038/onc.2014.79] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
26 Lee SH, Park JW, Woo SH, Go DM, Kwon HJ, Jang JJ, Kim DY. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice. Oncotarget 2016;7:87219-31. [PMID: 27888617 DOI: 10.18632/oncotarget.13529] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
27 Levesque C, Couture F, Kwiatkowska A, Desjardins R, Guérin B, Neugebauer WA, Day R. PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation. Oncotarget 2015;6:3680-93. [PMID: 25682874 DOI: 10.18632/oncotarget.2918] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
28 Wu PY, Li TM, Chen SI, Chen CJ, Chiou JS, Lin MK, Tsai FJ, Wu YC, Lin TH, Liao CC, Huang SM, Lin YN, Liang WM, Lin YJ. Complementary Chinese Herbal Medicine Therapy Improves Survival in Patients With Pemphigus: A Retrospective Study From a Taiwan-Based Registry. Front Pharmacol 2020;11:594486. [PMID: 33362549 DOI: 10.3389/fphar.2020.594486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Cipolla GA, Park JK, Lavker RM, Petzl-Erler ML. Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated Protein Kinase Activation? Front Immunol 2017;8:1022. [PMID: 28928733 DOI: 10.3389/fimmu.2017.01022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
30 Elbaiomy MA, Akl T, Elhelaly R, El-Beshbishi W, El Ghonemy MS, Elzehery R. Osteopontin level and promoter polymorphism in patients with metastatic breast cancer. Curr Oncol 2020;27:e444-50. [PMID: 33173383 DOI: 10.3747/co.27.6449] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Sun B, Zhang Z. [Advances in Research of Osteopontion and Its Receptor CD44v in Tumor Invasion and Metastasis]. Zhongguo Fei Ai Za Zhi 2015;18:714-7. [PMID: 26582229 DOI: 10.3779/j.issn.1009-3419.2015.11.11] [Reference Citation Analysis]
32 Qi QR, Xie QZ, Liu XL, Zhou Y. Osteopontin is expressed in the mouse uterus during early pregnancy and promotes mouse blastocyst attachment and invasion in vitro. PLoS One 2014;9:e104955. [PMID: 25133541 DOI: 10.1371/journal.pone.0104955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
33 Sun F, Xiong Y, Zhou XH, Li Q, Xiao L, Long P, Li LJ, Cai MY, Wei YX, Ma YL, Yu YH. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis. Tumour Biol 2016;37:6729-36. [PMID: 26662108 DOI: 10.1007/s13277-015-4498-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
34 Maeda N, Maenaka K. The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets. Int J Mol Sci 2017;18:E2198. [PMID: 29065446 DOI: 10.3390/ijms18102198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]